Creative Medical Technology shares are trading higher after the company announced it has received a Notice of Allowance for a US patent titled "SUPPRESSION OF DIABETES USING EXOSOMES FROM STEM CELL PROGRAMMED MYELOID CELLS".

Creative Medical shares are trading higher after the company announced that all patients have now been enrolled and treated across its FDA-cleared ADAPT clinical trial of CELZ-201 / Olastrocel, including the opioid expansion cohort.

Creative Medical Technology Says All Patients Enrolled And Treated Across ADAPT Trial Of Olastrocel In Chronic Lower Back Pain, Including FDA-Cleared Opioid Expansion Cohort; Trial Moves To Follow-Up And Phase 3 Planning

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers Jin Medical International (NASDAQ:ZJYL) stock rose 70.7% to $3.67 during Monday's pre-market session. The company's market cap stands at $16.8 million. As per the news, the H1 earnings report came out 4

Why Avalon Holdings Shares Are Trading Higher By More Than 10%; Here Are 20 Stocks Moving Premarket

Avalon Holdings (NYSE:AWX) shares rose 10.5% in pre-market trading after posting strong Q2 earnings of 23 cents per share and sales of $20.898 million. Other stocks gaining pre-market include DarkIris Inc (NASDAQ:DKI), Jin Medical International Ltd (NASDAQ:ZJYL), and Volato Group Inc (NYSE:SOAR).